World's Best Scientists 2026 revealed!
Takeshi Morimoto

Takeshi Morimoto

D-Index & Metrics

Medicine

D-Index
79
Citations
27713
World Ranking
17424
National Ranking
557

Overview

Takeshi Morimoto is affiliated with Kindai University in Japan and has contributed extensively to the field of medicine, with a primary focus on cardiology and cardiovascular medicine. Their research portfolio features a substantial number of publications addressing critical aspects of cardiovascular health, spanning various subfields including surgery, epidemiology, pulmonary and respiratory medicine, and internal medicine.

Their work engages deeply with key topics such as atrial fibrillation management and outcomes, venous thromboembolism diagnosis and management, acute ischemic stroke management, and coronary interventions and diagnostics. Antiplatelet therapy in cardiovascular diseases, acute myocardial infarction research, and cardiac imaging and diagnostics also represent prominent areas in their scholarly output.

Frequent publication venues for Takeshi Morimoto include several high-impact journals:

  • Circulation Journal
  • The American Journal of Cardiology
  • European Heart Journal
  • Circulation
  • Journal of the American Heart Association

Among recent papers associated with their research contributions are:

  • "Endovascular Therapy for Acute Stroke with a Large Ischemic Region" (2022, New England Journal of Medicine)
  • "Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome" (2022, JAMA Cardiology)
  • "Prevalence of post-intensive care syndrome among Japanese intensive care unit patients: a prospective, multicenter, observational J-PICS study" (2021, Critical Care)
  • "An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial" (2023, Circulation)
  • "Association with Controlling Nutritional Status (CONUT) Score and In-hospital Mortality and Infection in Acute Heart Failure" (2020, Scientific Reports)

Takeshi Morimoto has collaborated extensively with several researchers, frequently working alongside:

  • Takeshi Kimura
  • Kenji Andò
  • Kazushige Kadota
  • Yugo Yamashita
  • Hiroki Shiomi

The scope and depth of Morimoto's research contribute to ongoing studies in cardiovascular medicine with a particular emphasis on improving diagnostic and therapeutic strategies for acute and chronic cardiac conditions.

Best Publications

  • Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes A Randomized Controlled Trial

    Hisao Ogawa;Masafumi Nakayama;Takeshi Morimoto;Shiro Uemura

  • Predicting Successful Guidewire Crossing Through Chronic Total Occlusion of Native Coronary Lesions Within 30 Minutes : The J-CTO (Multicenter CTO Registry in Japan) Score as a Difficulty Grading and Time Assessment Tool

    Yoshihiro Morino;Mitsuru Abe;Takeshi Morimoto;Takeshi Kimura

  • Training and simulation for patient safety

    Rajesh Aggarwal;Oliver T. Mytton;Milliard Derbrew;David Hananel

  • Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial

    Hirotoshi Watanabe;Takenori Domei;Takeshi Morimoto;Masahiro Natsuaki

  • Adverse drug events and medication errors: detection and classification methods

    T Morimoto;T K Gandhi;A C Seger;T C Hsieh

  • Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome : A Multicenter Randomized Trial Evaluated by Volumetric Intravascular Ultrasound Using Pitavastatin Versus Atorvastatin (JAPAN-ACS [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome] Study)

    Takafumi Hiro;Takeshi Kimura;Takeshi Morimoto;Katsumi Miyauchi

  • In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan).

    Yoshihiro Morino;Takeshi Kimura;Yasuhiko Hayashi;Toshiya Muramatsu

  • High Incidence of NLRP3 Somatic Mosaicism in Patients With Chronic Infantile Neurologic, Cutaneous, Articular Syndrome: Results of an International Multicenter Collaborative Study

    Naoko Tanaka;Kazushi Izawa;Megumu K. Saito;Mio Sakuma

  • Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.

    Peter M Rothwell;Nancy R Cook;Nancy R Cook;J Michael Gaziano;Jacqueline F Price

  • Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis.

    Tomohiko Taniguchi;Takeshi Morimoto;Hiroki Shiomi;Kenji Ando

  • Early Immune-Related Adverse Events and Association with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study.

    Shunsuke Teraoka;Daichi Fujimoto;Takeshi Morimoto;Hayato Kawachi

  • Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.

    Takeshi Kimura;Takeshi Morimoto;Yoshihisa Nakagawa;Kazuya Kawai

  • Comparisons of Baseline Demographics, Clinical Presentation, and Long-Term Outcome Among Patients With Early, Late, and Very Late Stent Thrombosis of Sirolimus-Eluting Stents Observations From the Registry of Stent Thrombosis for Review and Reevaluation (RESTART)

    Takeshi Kimura;Takeshi Morimoto;Ken Kozuma;Yasuhiro Honda

  • Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent : A Randomized, Controlled, Noninferiority Trial

    Masahiro Natsuaki;Ken Kozuma;Takeshi Morimoto;Kazushige Kadota

  • Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection.

    Yasuhiro Kodera;Yoshitaka Yamamura;Yasuhiro Shimizu;Akihito Torii

  • An evaluation of risk factors for adverse drug events associated with angiotensin‐converting enzyme inhibitors

    Takeshi Morimoto;Takeshi Morimoto;Takeshi Morimoto;Tejal K. Gandhi;Tejal K. Gandhi;Julie M. Fiskio;Andrew C. Seger

  • Survival after curative resection for mucinous adenocarcinoma of the colorectum.

    Yukihide Kanemitsu;Tomoyuki Kato;Takashi Hirai;Kenzo Yasui

  • Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study

    Hiroki Shiomi;Yoshihisa Nakagawa;Takeshi Morimoto;Yutaka Furukawa

  • Effect of Dexmedetomidine on Mortality and Ventilator-Free Days in Patients Requiring Mechanical Ventilation With Sepsis: A Randomized Clinical Trial.

    Yu Kawazoe;Kyohei Miyamoto;Takeshi Morimoto;Tomonori Yamamoto

  • Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents 1-Year Outcomes from the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial (RESET)

    Takeshi Kimura;Takeshi Morimoto;Masahiro Natsuaki;Hiroki Shiomi

Frequent Co-Authors

Takeshi Kimura
Takeshi Kimura Kyoto University
Yasuhiro Kodera
Yasuhiro Kodera Nagoya University
Toru Kita
Toru Kita Kyoto University
Hisao Ogawa
Hisao Ogawa Kumamoto University
Minoru Horie
Minoru Horie Shiga University of Medical Science
Yoshihiko Saito
Yoshihiko Saito Nara Medical University
Atsushi Nakagawa
Atsushi Nakagawa Osaka University
David W. Bates
David W. Bates Brigham and Women's Hospital
Toshio Heike
Toshio Heike Kyoto University
Masunori Matsuzaki
Masunori Matsuzaki Yamaguchi University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in the healthcare field, but not sure if medical school is the right path? There are several affordable and rewarding online programs that can launch your career in healthcare, even without a medical degree.

Technology-driven students may consider a health information technology online degree. This pathway prepares you for roles managing patient records, data security, and healthcare IT systems.

If you’re detail-oriented, look into the medical coding certification cost and programs. These certifications allow you to work in medical billing and coding, which are vital for the business side of healthcare.

For those aiming to provide direct care, there are many cheapest fnp programs online that train you to become a Family Nurse Practitioner—a high-demand, advanced nursing role.

If nursing appeals to you and you want to fast-track your education, explore the cheapest online accelerated bsn programs. These programs help you become a registered nurse in less time, with flexible online options.

Exploring these online degrees opens doors to fulfilling, high-impact careers in healthcare—often at a lower cost and with greater convenience than traditional medical school.

Best Scientists Citing Takeshi Morimoto

Trending Scientists